Adenosine 3':5'-cyclic monophosphate as a mediator in the action of neurohumoral agents.
D000200:Action Potentials; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001338:Autonomic Fibers, Postganglionic / Q000378:metabolism / Q000502:physiology; D001339:Autonomic Fibers, Preganglionic / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D004298:Dopamine / Q000494:pharmacology; D004558:Electric Stimulation; D004594:Electrophysiology / Q000187:drug effects; D005725:Ganglia, Autonomic / Q000378:metabolism / Q000502:physiology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009433:Neural Inhibition; D009638:Norepinephrine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000502:physiology; D010646:Phentolamine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000502:physiology; D009435:Synaptic Transmission; D013806:Theophylline / Q000494:pharmacology
D006584:Hexamethonium Compounds; D011453:Prostaglandins; D001285:Atropine; D013806:Theophylline; D000242:Cyclic AMP; D011494:Protein Kinases; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine